StockWatch
·
Specialty Chemicals
Quarterly Result16 Oct 2026, 05:10 pm

Paushak Q2 FY27: standalone PAT +57% YoY to ₹13.5 Cr, OPM up 430bps; QoQ softer on tax

AI Summary

Paushak's standalone revenue from operations came in at ₹89.32 Cr, up 51.9% YoY (₹58.78 Cr) and 6.9% QoQ (₹83.55 Cr), with PAT of ₹13.51 Cr, up 56.9% YoY (₹8.61 Cr) but down 10.6% QoQ (₹15.10 Cr). Basic EPS was ₹5.48 against a restated ₹3.49 a year ago and ₹6.13 last quarter. Only a standalone statement was filed — the company has one reportable segment and no consolidated results. Operating margin (EBITDA on revenue from operations) expanded 430bps YoY to 29.5% from 25.2%, pointing to operating leverage on higher volumes, though it eased 119bps from Q1FY27's 30.7%. Net margin was roughly flat YoY (14.8% vs 14.4%) but down from 17.4% last quarter. The sequential profit decline was tax-driven rather than operational: PBT was nearly flat QoQ (₹18.60 Cr vs ₹19.02 Cr, -2.2%), but the effective tax rate jumped to 27.4% from 20.6% in Q1FY27 (current tax ₹2.74 Cr + deferred tax ₹2.35 Cr, versus ₹2.49 Cr + ₹1.42 Cr), pulling PAT down 10.6% QoQ. Finance costs also stepped up to ₹1.35 Cr from a near-nil ₹0.04 Cr a year earlier, and depreciation nearly doubled YoY (₹8.44 Cr vs ₹4.47 Cr) — both consistent with the FY26 capex/borrowing build (₹35 Cr of non-current borrowing proceeds were raised in H1FY26 per the cash-flow statement, with ₹7.5 Cr repaid in the current half). No analyst coverage exists for this stock (TipRanks shows zero covering analysts), so there is no street estimate to grade this print against, and management has issued no formal guidance on record — this result cannot be benchmarked to either. No management press release accompanied the filing for additional commentary. The quarter's corporate calendar — the October 16 board meeting, the October 1 trading-window closure, and the July 30 AGM — was procedural, with no capacity, deal, or management-change events feeding into the numbers. With PBT nearly flat sequentially, the swing factor going into Q3 is the effective tax rate — whether it holds near 27% or reverts toward the ~20-21% seen through H1 — alongside whether operating margin stabilises in the 29-31% band now that the finance-cost and depreciation step-up from FY26 capex has largely annualised.

Key Highlights

  • Revenue from operations ₹89.32 Cr, +51.9% YoY, +6.9% QoQ
  • PAT ₹13.51 Cr, +56.9% YoY, -10.6% QoQ; EPS ₹5.48 vs restated ₹3.49 YoY, ₹6.13 QoQ
  • OPM (EBITDA/revenue) 29.5%, up 430bps YoY from 25.2%, but down 119bps QoQ from 30.7%
  • Effective tax rate rose to 27.4% from 20.6% in Q1FY27, the key driver of the QoQ PAT decline despite PBT nearly flat (-2.2% QoQ)
  • Finance costs ₹1.35 Cr vs ₹0.04 Cr YoY and depreciation ₹8.44 Cr vs ₹4.47 Cr YoY, reflecting FY26 capex funded by ₹35 Cr of non-current borrowings
  • Paid-up equity capital ₹12.33 Cr vs ₹3.08 Cr YoY on a bonus/stock-split action — EPS comparisons must use the restated ₹3.49 base, not unadjusted prior figures